NEW YORK (GenomeWeb News) – An alliance consisting of health insurance and pharmaceutical companies, hospitals, union interests, and biomedical firms focused on providing wellness programs, has asked the Obama Administration to put a hold on the final regulations of the Genetic Information Non-discrimination Act of 2008 (GINA), claiming that part of the rules will cause the use of such programs to "decline precipitously."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.